Chammas & Marcheteau advised Hoppen and its historical partners on the investment in its capital by Après-demain SA. Après-demain SA, the parent company of Debiopharm active...
Après-demain’s Acquisition of a Stake in Hoppen
Wichard’s LBO
Chammas & Marcheteau advised a consortium of investment funds. The sellers were advised by Lamartine Conseil. The management was advised by Lamartine Conseil. The senior lenders...
Horizontal Software’s Acquisition of SoWeSign
Chammas & Marcheteau advised Horizontal Software on the deal Horizontal Software executed the acquisition of SoWeSign. Horizontal Software specializes in publishing human capital management software in SaaS...
Treatwell France’s Acquisition of Wavy
Osborne Clarke advised Treatwell France on the deal. Chammas & Marcheteau advised Wavy. The Treatwell group – the leading beauty and wellness site and app in...
Sofia Développement’s Acquisition of ComptaSanté
IN BRIEF: Chammas & Marcheteau, advised on the matter. Chammas & Marcheteau advised Sofia Développement with a team including Nicolas Lecocq (Picture – Corporate M&A). Read...
Frio’s Acquisition of Temptech
IN BRIEF: Chammas & Marcheteau, advised on the matter. Chammas & Marcheteau advised Frio SA with a team including Pierre-Louis S?egrand (Picture – Corporate M&A). Read...
Azulis Capital’s Investment in Phocéenne de Cosmétique
IN BRIEF: Chammas & Marcheteau, Hoche Société d’Avocats, advised on the matter. Chammas & Marcheteau advised Azulis Capital, BNP Paribas with a team including Christophe Moreau...